4
Changes in Ownership
Acurx Pharmaceuticals, Inc. Filed Acc 0001104659-26-046833
Options or other derivatives
- Chief Financial Officer acquired 25,900 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Shawah Robert G. Chief Financial Officer | 2026-04-20 | Grant or award · Stock Option | +25,900 | 25,900 | D | ||
Loading xslF345X06/tm2612397-1_4seq1.xml…